$2.32 Billion is the total value of NEA Management Company, LLC's 44 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 16.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TSRO | TESARO INC | $406,506,000 | -12.3% | 10,420,555 | 0.0% | 17.54% | -19.2% | |
| ADAP | Buy | ADAPTIMMUNE THERAPEUTICS PLCadr | $214,690,000 | +35.7% | 15,832,611 | +18.8% | 9.26% | +25.0% |
| SENS | SENSEONICS HOLDINGS INC | $147,337,000 | +16.1% | 30,888,266 | 0.0% | 6.36% | +6.9% | |
| RYTM | RHYTHM PHARMACEUTICALS INC | $143,292,000 | -6.7% | 4,912,306 | 0.0% | 6.18% | -14.1% | |
| GLYC | GLYCOMIMETICS INC | $130,882,000 | -10.7% | 9,089,041 | 0.0% | 5.65% | -17.8% | |
| ALLK | New | ALLAKOS INC | $102,046,000 | – | 2,268,188 | +100.0% | 4.40% | – |
| RARX | RA PHARMACEUTICALS INC | $99,380,000 | +81.8% | 5,493,636 | 0.0% | 4.29% | +67.4% | |
| CRSP | CRISPR THERAPEUTICS AGnamen akt | $92,722,000 | -24.5% | 2,090,678 | 0.0% | 4.00% | -30.5% | |
| OBSV | OBSEVA SA | $82,696,000 | +19.1% | 4,586,563 | 0.0% | 3.57% | +9.7% | |
| MRSN | MERSANA THERAPEUTICS INC | $81,443,000 | -44.0% | 8,144,267 | 0.0% | 3.51% | -48.4% | |
| EPZM | EPIZYME INC | $68,485,000 | -21.8% | 6,460,851 | 0.0% | 2.96% | -27.9% | |
| LQDA | New | LIQUIDIA TECHNOLOGIES INC | $68,193,000 | – | 2,486,062 | +100.0% | 2.94% | – |
| ARDX | ARDELYX INC | $66,707,000 | +17.6% | 15,335,047 | 0.0% | 2.88% | +8.3% | |
| AVEO | Buy | AVEO PHARMACEUTICALS INC | $61,891,000 | +54.4% | 18,698,038 | +5.1% | 2.67% | +42.2% |
| SYBX | SYNLOGIC INC | $60,100,000 | +44.6% | 4,229,410 | 0.0% | 2.59% | +33.1% | |
| BE | New | BLOOM ENERGY CORP | $45,440,000 | – | 1,333,333 | +100.0% | 1.96% | – |
| DERM | DERMIRA INC | $38,222,000 | +18.5% | 3,506,649 | 0.0% | 1.65% | +9.1% | |
| SURF | SURFACE ONCOLOGY INC | $36,268,000 | -32.9% | 3,315,149 | 0.0% | 1.56% | -38.2% | |
| AUPH | AURINIA PHARMACEUTICALS INC | $31,928,000 | +17.9% | 4,808,483 | 0.0% | 1.38% | +8.7% | |
| CSBR | CHAMPIONS ONCOLOGY INC | $27,297,000 | +175.6% | 1,562,500 | 0.0% | 1.18% | +153.9% | |
| RGLS | Sell | REGULUS THERAPEUTICS INC | $26,044,000 | +259.5% | 10,989,010 | -0.0% | 1.12% | +231.6% |
| LXRX | LEXICON PHARMACEUTICALS INC | $25,419,000 | -11.1% | 2,382,286 | 0.0% | 1.10% | -18.1% | |
| MEIP | MEI PHARMA INC | $24,656,000 | +9.4% | 5,720,572 | 0.0% | 1.06% | +0.8% | |
| CMTA | CLEMENTIA PHARMACEUTICALS INC | $23,880,000 | -15.3% | 2,141,697 | 0.0% | 1.03% | -22.0% | |
| AFMD | AFFIMED NV | $22,354,000 | +163.6% | 5,138,888 | 0.0% | 0.96% | +143.1% | |
| AKAOQ | ACHAOGEN INC | $20,808,000 | -53.9% | 5,215,128 | 0.0% | 0.90% | -57.6% | |
| SBBP | STRONGBRIDGE BIOPHARMA PLC | $20,085,000 | -19.2% | 4,141,308 | 0.0% | 0.87% | -25.5% | |
| GNCA | GENOCEA BIOSCIENCES INC | $19,500,000 | -8.2% | 25,000,000 | 0.0% | 0.84% | -15.6% | |
| VRNA | VERONA PHARMA PLCads | $15,258,000 | -8.4% | 1,219,674 | 0.0% | 0.66% | -15.7% | |
| NITE | NIGHTSTAR THERAPEUTICS PLCadr | $14,593,000 | +27.7% | 714,285 | 0.0% | 0.63% | +17.8% | |
| ARQL | ARQULE INC | $14,265,000 | +2.4% | 2,520,316 | 0.0% | 0.62% | -5.7% | |
| DZSI | DASAN ZHONE SOLUTIONS INC | $13,569,000 | +45.4% | 956,255 | 0.0% | 0.59% | +34.1% | |
| PTI | PROTEOSTASIS THERAPEUTICS INC | $13,392,000 | -13.6% | 5,556,778 | 0.0% | 0.58% | -20.4% | |
| RIGL | RIGEL PHARMACEUTICALS INC | $10,411,000 | +13.4% | 3,243,150 | 0.0% | 0.45% | +4.4% | |
| CTIC | CTI BIOPHARMA CORP | $8,100,000 | -56.6% | 3,750,000 | 0.0% | 0.35% | -60.0% | |
| TRVN | TREVENA INC | $8,081,000 | +47.2% | 3,811,691 | 0.0% | 0.35% | +35.8% | |
| TRILLIUM THERAPEUTICS INC | $7,250,000 | -3.3% | 1,250,000 | 0.0% | 0.31% | -10.8% | ||
| TCON | TRACON PHARMACEUTICALS INC | $7,108,000 | -24.1% | 3,467,181 | 0.0% | 0.31% | -30.1% | |
| ERYP | ERYTECH PHARMA SAadr | $5,356,000 | -23.3% | 625,000 | 0.0% | 0.23% | -29.4% | |
| ELGX | ENDOLOGIX INC | $4,756,000 | -66.3% | 2,490,204 | 0.0% | 0.20% | -68.9% | |
| ASNS | ARSANIS INC | $3,240,000 | -55.4% | 2,000,000 | 0.0% | 0.14% | -58.8% | |
| SNSS | SUNESIS PHARMACEUTICALS INC | $2,597,000 | -5.6% | 1,298,274 | 0.0% | 0.11% | -13.2% | |
| AKTX | AKARI THERAPEUTICS PLCadr | $1,158,000 | +31.3% | 452,167 | 0.0% | 0.05% | +22.0% | |
| AYTU | New | AYTU BIOSCIENCE INC | $6,000 | – | 2,246 | +100.0% | 0.00% | – |
| AYTU | Exit | AYTU BIOSCIENCE INC | $0 | – | -44,908 | -100.0% | -0.00% | – |
| TNTRQ | Exit | TINTRI INC | $0 | – | -5,253,358 | -100.0% | -0.06% | – |
| MDB | Exit | MONGODB INCcl a | $0 | – | -150,000 | -100.0% | -0.35% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-11-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GLYCOMIMETICS INC | 39 | Q3 2023 | 7.6% |
| AURINIA PHARMACEUTICALS INC | 37 | Q3 2023 | 5.0% |
| CHAMPIONS ONCOLOGY INC | 33 | Q3 2023 | 1.2% |
| LEXICON PHARMACEUTICALS INC | 32 | Q3 2023 | 2.0% |
| ADAPTIMMUNE THERAPEUTICS PLC | 31 | Q3 2023 | 9.3% |
| TREVENA INC | 31 | Q3 2021 | 3.3% |
| AKARI THERAPEUTICS PLC | 31 | Q2 2023 | 0.3% |
| ARDELYX INC | 29 | Q3 2021 | 11.9% |
| RIGEL PHARMACEUTICALS INC | 29 | Q2 2020 | 0.6% |
| EPIZYME INC | 28 | Q1 2020 | 9.6% |
View NEA Management Company, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-10 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-12 |
View NEA Management Company, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.